The Fort Worth Press - Medical Care Technologies Inc. (OTCID:MDCE) Advances Melanoma Scan Beta With Next-Week Results Posting

USD -
AED 3.673042
AFN 65.000368
ALL 81.855041
AMD 360.540403
ANG 1.790403
AOA 918.000367
ARS 1546.131265
AUD 1.476887
AWG 1.8
AZN 1.70397
BAM 1.769883
BBD 2.014669
BDT 124.411223
BGN 1.77347
BHD 0.37715
BIF 3005
BMD 1
BND 1.287984
BOB 11.678099
BRL 5.666304
BSD 1.000231
BTN 94.214794
BWP 13.981141
BYN 2.99667
BYR 19600
BZD 2.011773
CAD 1.42715
CDF 2315.000362
CHF 0.838719
CLF 0.025287
CLP 995.220396
CNY 6.67175
CNH 6.67522
COP 3319.97
CRC 448.217041
CUC 1
CUP 24.005936
CVE 100.150394
CZK 22.139304
DJF 177.720393
DKK 6.782304
DOP 60.703884
DZD 137.227489
EGP 53.502064
ERN 15
ETB 161.050392
EUR 0.90715
FJD 2.25325
FKP 0.756884
GBP 0.75683
GEL 2.590391
GGP 0.756884
GHS 11.72504
GIP 0.756884
GMD 74.000355
GNF 8857.503848
GTQ 7.646644
GYD 209.264655
HKD 7.84565
HNL 26.950388
HRK 6.831965
HTG 131.169348
HUF 331.003504
IDR 18235.4
ILS 3.216704
IMP 0.756884
INR 94.25795
IQD 1514
IRR 1913737.503816
ISK 123.930386
JEP 0.756884
JMD 158.047862
JOD 0.70904
JPY 159.72504
KES 130.050385
KGS 87.435504
KHR 4080.00035
KMF 447.00035
KPW 900.00035
KRW 1336.565039
KWD 0.31147
KYD 0.833529
KZT 445.849094
LAK 22530.000349
LBP 89550.000349
LKR 332.687818
LRD 170.000348
LSL 16.930381
LTL 2.95274
LVL 0.60489
LYD 6.445039
MAD 9.961704
MDL 18.169149
MGA 4590.000347
MKD 55.830725
MMK 2099.848767
MNT 3604.365716
MOP 8.083632
MRU 40.603743
MUR 47.620378
MVR 15.403739
MWK 1736.000345
MXN 18.536504
MYR 4.086104
MZN 63.903729
NAD 16.930377
NGN 1343.570377
NIO 36.803722
NOK 9.57248
NPR 150.739077
NZD 1.809628
OMR 0.385141
PAB 1.000231
PEN 3.403039
PGK 4.511504
PHP 63.960375
PKR 276.603701
PLN 3.996535
PYG 6207.891986
QAR 3.64425
RON 4.851904
RSD 106.559038
RUB 82.829047
RWF 1476
SAR 3.77446
SBD 8.097697
SCR 13.945304
SDG 601.503676
SEK 10.075038
SGD 1.287204
SHP 0.752984
SLE 23.050371
SLL 20969.503664
SOS 572.503662
SRD 37.49037
STD 20697.981008
STN 22.2
SVC 8.752585
SYP 13002.000337
SZL 16.930369
THB 33.875038
TJS 9.227282
TMT 3.5
TND 3.008504
TOP 2.40776
TRY 50.342104
TTD 6.789769
TWD 32.891404
TZS 2648.920367
UAH 45.477786
UGX 4131.053487
UYU 40.541335
UZS 12039.000334
VES 912.87925
VND 25725.5
VUV 120.638016
WST 2.81058
XAF 595.051667
XAG 0.020459
XAU 0.00025782798
XCD 2.70255
XCG 1.802699
XDR 0.707052
XOF 595.051667
XPF 108.325037
YER 236.550363
ZAR 16.976255
ZMK 9001.203584
ZMW 20.450473
ZWL 321.999592
SSP 5946.454122
MXV 2.081672
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Medical Care Technologies Inc. (OTCID:MDCE) Advances Melanoma Scan Beta With Next-Week Results Posting
Medical Care Technologies Inc. (OTCID:MDCE) Advances Melanoma Scan Beta With Next-Week Results Posting

Medical Care Technologies Inc. (OTCID:MDCE) Advances Melanoma Scan Beta With Next-Week Results Posting

Larger Human-Submitted Dataset Now Ready for Public Technical Update as Testing Continues

Text size:

MESA, AZ / ACCESS Newswire / October 20, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced that updated internal evaluation results for MDCE Melanoma Scan Beta will be posted on the Company's corporate website next week.

The results will be available at https://www.medicalcaretechnologies.com.

This update follows the Company's October 8 announcement that volunteer intake remained open and that a next-round evaluation would be published. That sequence now reaches the reporting step. The posting will cover the same three technical layers already under review:

  • Image intake and quality scoring - whether new user photographs can be received and separated into usable and held-out samples
  • Body-map registration - whether images can be placed on the interactive body map so the same skin area can be found again
  • Change-over-time comparison - whether successive images of a mapped area can be organized for visual review

The program has already moved through volunteer intake (September 4), receipt of the first human-submitted datasets (September 16), the start of internal review (September 23), and first-pass results (September 29). The first pass showed that real-world user photographs could move through the three layers. The next-week posting is the expanded readout on the larger set of submissions collected since then.

Until the volunteer phase, model work centered on public dermatology archives, including HAM10000, ISIC Archive collections, and TCIA melanoma cohorts. Human-submitted images add lighting, device type, distance, angle, compression, and everyday image quality that those archives do not fully capture. The upcoming results reflect continued testing against that real-world variability.

"The first pass showed the workflow can run on photographs people actually take," said Marshall Perkins, CEO of Medical Care Technologies. "Next week we post the next readout on the expanded set. Intake remains open because a wider test set strengthens the evaluation."

MDCE Melanoma Scan Beta is being developed as an AI-assisted imaging and body-map monitoring application intended to help users catalog visible skin images and review the same mapped area across sessions. The platform remains in beta-stage development. It has not received regulatory clearance and is not intended to treat, cure, or prevent any disease or medical condition. It is not a substitute for professional medical advice, screening, or evaluation by a qualified healthcare provider.

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID: MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. Visit: https://www.medicalcaretechnologies.com

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding planned publication of evaluation updates. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.

Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: [email protected]
Website: https://www.medicalcaretechnologies.com

SOURCE: Medical Care Technologies Inc.



View the original press release on ACCESS Newswire

G.George--TFWP